Skip to main content
SearchLogin or Signup

Reviews of "Impact of Glucose-Lowering Drugs on Mortality and Other Adverse Outcomes in Patients with Type 2 Diabetes Admitted for COVID-19"

Reviewers: Susanna Hofmann (Helmholtz Diabetes Center) | 📗📗📗📗◻️ • L Marie (Albert Einstein Medical Center) | 📒📒📒◻️◻️

Published onOct 16, 2020
Reviews of "Impact of Glucose-Lowering Drugs on Mortality and Other Adverse Outcomes in Patients with Type 2 Diabetes Admitted for COVID-19"

To read the original manuscript, click the link above.

Summary of Reviews: Glucose-lowering medications have a neutral effect on mortality and adverse outcomes in those with Type 2 Diabetes hospitalized. While this study is strong, drugs used during the hospital stay were not noted, making these conclusions hard to generalize.

Reviewer 1 (Susanna Hofmann) | 📗📗📗📗◻️

Reviewer 2 (Tamaryn Fox) | 📒📒📒 ◻️◻️

RR:C19 Strength of Evidence Scale Key

📕 ◻️◻️◻️◻️ = Misleading

📙📙 ◻️◻️◻️ = Not Informative

📒📒📒 ◻️◻️ = Potentially Informative

📗📗📗📗◻️ = Reliable

📘📘📘📘📘 = Strong

To read the reviews, click the links below.

Comments
0
comment

No comments here